Skip to main navigation Skip to search Skip to main content

Development of broadly applicable combinatorial genome editing and antisense therapies for Duchenne muscular dystrophy addressing dystrophin deficiency, muscle wasting and muscle fibrosis

Project: Research

Project Details

StatusFinished
Effective start/end date1/10/1530/09/16

Funding

  • Muscular Dystrophy UK: £74,900.00